Depression is a prevalent mental health disorder that has high social and economic costs around the world. Currently, over 45 million people in the United States are immigrants. Immigration can be a source of stress, and therefore examining the difference between rates of depression between U.S. citizens and non-U.S. citizens could shine a light on […]
B30: Does Coadministration of Marijuana and CNS-active Medications Increase Risk of Hypersomnolence in Young Adults
Author(s): Lily Davidson, Public Health and Premedical Studies Major Advisor(s): Saruna Ghimire, Sociology and Gerontology
A12: The Effects of Hormonal Birth Control on Depression in Women
It has been found that more women in the United States have depression than men. Several studies have been conducted looking into possible explanations for this occurrence. One such topic of study has been the effects of hormonal birth control on depression in women. Studies have been conducted in an assortment of different countries and […]
A15: Depression and Sleep Disorders in Adults Aged 20+: A Cross-Sectional Study
Sleep disorders are the second most common cause of depression in the United States. When prolonged, sleep disorders not only cause psychiatric disorders, but also hypertension, heart attacks and strokes. Currently, there are no studies confirming the relationship between sleep disorders and depression using the National Health and Nutrition Examination Survey (NHANES) data from 2017-2018. […]
A18: Enzymatic Conversion of Psilocybin and Related Tryptamines by Alkaline Phosphatase and Monoamine Oxidase A
The McMurray lab is a behavioral neuroscience lab that focuses on the study of tryptamines commonly found in “magic” mushrooms. The main tryptamine found in these mushrooms is psilocybin, and this has been extensively studied as a therapeutic because of its promising antidepressant effects. The leading theory for why psilocybin possesses this antidepressant efficacy is […]
A22: High Blood Pressure and Depression in U.S. Adults: a Cross-sectional Study
Introduction Depression is a complex mental illness that has many possible risk factors. Approximately 21 million adults in the United States suffer from major depressive disorder. The comorbidities linked to depression are contributing to an increasing economic burden on the United States. Additionally, there are over 116 million adults in the United States that have […]
C46: Psilocybin as a Preventative Measure for Alcohol Dependence
Alcohol addiction is a widespread problem that affects people of all ages and backgrounds, yet it is not very well treated. Addiction is commonly referred to as a sickness or disease, but is set apart from other diseases in that there is a lack of medications that provide a cure or alleviate symptoms. With the […]
C47: Rodent Behavioral and Antidepressant Effects of Psilocybin and Novel Tryptamines
Clinical trials on the use of psilocybin to treat depression are promising, but still in preliminary stages. Additionally, they are confounded by the presence of hallucinations, which may not be necessary for its clinical effectiveness but create significant challenges in experimental design. Thus, there is a need to determine if other tryptamines have similar molecular […]